Sanofi SA Mergers and Acquisitions Summary

Life Science Company

Sanofi SA has acquired 23 companies, including 3 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 12 assets.

Sanofi SA’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi SA has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include life science (58%) and medical products (20%).

Join Mergr and gain access to Sanofi SA’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity33
    • M&A Buy Activity21
    • M&A Sell Activity12
  • Total Sectors Invested 5
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 22
  • M&A Advisors 6

Sanofi SA

54, Rue La Boétie,
Paris, 75008
France,
+33 1 53 77 40 00
www.sanofi.com

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1973 and is based in Paris, France.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.6/yr) # 18 - - 2 - 1 21
vol $29.1B $11.6B $40.7B
Sell (2.0/yr) # 2 2 2 4 1 1 12
vol $425M $94M $2.2B $350M $3.0B
  33

Most Recent M&A

Company Date Value Type
Chattem, Inc. 2020-03-20 - Divestiture
Chattanooga, Tennessee · www.kaopectate.com
Synthorx, Inc. 2020-01-23 - Add-on Acquisition
La Jolla, California · www.synthorx.com
sanofi-aventis U.S. LLC (Seprafilm Adhesion Barrier) 2019-12-02 350M USD Divestiture
, United States · www.seprafilm.us
Sanofi SA - Inhalation Contract Manufacturing Business 2018-10-01 - Divestiture
Paris, France
Ablynx NV 2018-06-19 - Add-on Acquisition
Zwijnaarde, Belgium · www.ablynx.com
Sanofi SA - Infectious diseases 2018-06-18 - Divestiture
Paris, France
Zentiva Group, a.s. 2018-04-17 2.2B EUR Divestiture
Prague, Czech Republic · www.zentiva.cz
Sanofi SA - Leukine 2018-02-01 - Divestiture
Paris, France
Bioverativ, Inc. 2018-01-22 11.6B USD Add-on Acquisition
Waltham, Massachusetts · www.bioverativ.com
Winthrop Pharma Senegal 2017-04-19 - Divestiture
Dakar, Senegal
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Genzyme Corp. 2011-02-16 Caprelsa 2015-07-27 1
Cambridge, Massachusetts · www.genzyme.com , United Kingdom · www.caprelsarems.com
Merial Ltd. 2009-07-30 Dosch - Animal Health Division 2012-12-20 1
Duluth, Georgia · www.merial.us , India

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 12 (57%) 33.4B (82%) 7 (58%) 2.7B (88%)
Medical Products 4 (19%) 4.0B (10%) 2 (17%) 350M (12%)
Consumer Products 3 (14%) 2.3B (6%) 2 (17%) -
Business Services 1 (5%) 563M (1%) - -
Healthcare Services 1 (5%) 417M (1%) - -
Chemicals - - 1 (8%) -
Total 21 $40.7B 12 $3.0B

By Geo

State/Country Buy Value Sell Value
United States 12 39.3B 3 775M
  Massachusetts 3 31.7B - -
  California 3 1.1B - -
  Tennessee 1 1.9B 1 -
  Pennsylvania 1 - - -
  New York 1 563M - -
  Georgia 1 4.0B - -
  Florida 1 - - -
  New Jersey - - 1 425M
France 2 417M 7 94M
Czech Republic 1 - 1 2.2B
Australia 1 399M - -
Belgium 1 - - -
Brazil 1 563M - -
Colombia 1 - - -
India 1 - - -
Senegal - - 1 -
Switzerland 1 - - -
Domestic 2 (10%) 417M (1%) 7 (58%) 94M (3%)
Cross-border 19 (90%) 40.3B (99%) 5 (42%) 2.9B (97%)
Total 21 $40.7B 12 $3.0B

Top M&A Advisors

Financial Deals
Morgan Stanley
1
J.P. Morgan Securities LLC
1
Evercore Group LLC
1
Legal Deals
Weil Gotshal & Manges LLP
3
Jones Day
1

Deal Values

buy # Total
> $1B 4 $37.6B
$100M to $1B 6 $3.1B
TOTAL $40.7B
Largest Genzyme Corp.
$20.1B (2011-02-16)
sell # Total
> $1B 1 $2.2B
$100M to $1B 2 $775M
< $100M 1 $94M
TOTAL $3.0B
Largest Zentiva Group, a.s.
$2.2B (2018-04-17)

M&A Connections

Deals %
Acquired from
PE Firm(s)
70%
7 70%
Strategic(s)
30%
3 30%
Divested to
PE Firm(s)
8%
1 8%
Strategic(s)
92%
11 92%

 Subscribe to unlock this and 153,348
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 141K M&A Transactions
  • 149K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 42K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.